Related references
Note: Only part of the references are listed.miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1
Guoqiang Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell
Rosalba Perrone et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma
Marcela Gimenez et al.
BMC CANCER (2015)
Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway
Qingchun Mu et al.
CANCER BIOLOGY & THERAPY (2015)
Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays
Huile Gao et al.
ACTA BIOMATERIALIA (2014)
A dual functional fluorescent probe for glioma imaging mediated by Blood-brain barrier penetration and glioma cell targeting
Hongwei Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy
Nikolina Vlatkovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
DNA and RNA Quadruplex-Binding Proteins
Vaclav Brazda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg et al.
INVESTIGATIONAL NEW DRUGS (2014)
Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Marina Koutsioumpa et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2014)
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
Yona Goldshmit et al.
ONCOTARGET (2014)
In vitro and in vivo Evaluation of Antitumor Drug-Loaded Aptamer Targeted Single-Walled Carbon Nanotubes System
Huijuan Zhang et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2013)
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Glycosilated nucleolin as marker for human gliomas
R. Galzio et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest
Zhiqiang Xu et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
RNA-binding protein nucleolin in disease
Kotb Abdelmohsen et al.
RNA BIOLOGY (2012)
Insights into the biomedical effects of carboxylated single-wall carbon nanotubes on telomerase and telomeres
Yong Chen et al.
NATURE COMMUNICATIONS (2012)
Akt signalling in health and disease
Ingeborg Hers et al.
CELLULAR SIGNALLING (2011)
Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs
Kotb Abdelmohsen et al.
NUCLEIC ACIDS RESEARCH (2011)
MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251
Shihai Luan et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Post-transcriptional and post-translational regulation of Bcl2
Shaun Willimott et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Nucleolin on the Cell Surface as a New Molecular Target for Gastric Cancer Treatment
Tatsuro Watanabe et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Mechanism of Regulation of bcl-2 mRNA by Nucleolin and A plus U-rich Element-binding Factor 1 (AUF1)
Daniella Ishimaru et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Oncogenic EGFR Signaling Networks in Glioma
Paul H. Huang et al.
SCIENCE SIGNALING (2009)
The nucleolin targeting aptamer AS1411 destabilizes bcl-2 messenger RNA in human breast cancer cells
Sridharan Soundararajan et al.
CANCER RESEARCH (2008)
AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin
Yun Teng et al.
CANCER RESEARCH (2007)
Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication
Iva Ugrinova et al.
BMC MOLECULAR BIOLOGY (2007)
Nucleolin: a multiFACeTed protein
Fabien Mongelard et al.
TRENDS IN CELL BIOLOGY (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Discovery and development of anticancer aptamers
Christopher R. Ireson et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin
M Takagi et al.
CELL (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization
TK Sengupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bidirectional DNA unwinding by a ternary complex of T antigen, nucleolin and topoisomerase I
S Seinsoth et al.
EMBO REPORTS (2003)
Nucleic-acid therapeutics: Basic principles and recent applications
JB Opalinska et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Negative regulation of bcl-2 expression by p53 in hematopoietic cells
YL Wu et al.
ONCOGENE (2001)
Share Paper
